SCOR SE (EPA:SCR)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,997	4,234	4,748	3,833	5,065	4,909
Market Cap Growth	18.34%	-10.83%	23.88%	-24.34%	3.17%	-29.55%
Enterprise Value	8,481	7,672	8,416	7,353	5,680	6,100
PE Ratio	9.40	1058.39	5.85	-	11.11	20.98
PS Ratio	0.31	0.26	0.29	0.24	0.29	0.29
PB Ratio	0.80	0.64	0.69	0.59	0.62	0.80
P/FCF Ratio	4.43	4.84	3.28	8.91	2.18	5.76
P/OCF Ratio	4.30	4.69	3.21	7.67	2.11	4.97
EV/Sales Ratio	0.53	0.47	0.52	0.46	0.32	0.36
EV/EBITDA Ratio	8.30	18.49	5.86	-	6.75	10.97
EV/EBIT Ratio	9.33	24.12	6.27	-	7.15	12.55
EV/FCF Ratio	7.53	8.77	5.82	17.10	2.45	7.15
Debt / Equity Ratio	0.56	0.54	0.47	0.51	0.39	0.52
Debt / EBITDA Ratio	3.48	8.04	2.22	-	3.71	5.51
Debt / FCF Ratio	3.13	4.07	2.24	7.66	1.39	3.77
Quick Ratio	2.71	2.37	2.46	2.91	0.36	0.42
Current Ratio	4.45	3.97	4.08	4.80	0.79	0.84
Asset Turnover	0.45	0.45	0.46	0.37	0.36	0.37
Return on Equity (ROE)	8.40%	0.06%	12.14%	-18.82%	6.33%	3.67%
Return on Assets (ROA)	1.62%	0.55%	2.38%	-2.26%	1.02%	0.65%
Return on Capital (ROIC)	5.87%	1.96%	8.44%	-9.23%	4.77%	3.23%
Earnings Yield	10.83%	0.09%	17.10%	-36.09%	9.00%	4.77%
Earnings Yield	10.83%	0.09%	17.10%	-36.09%	9.00%	4.77%
FCF Yield	22.55%	20.67%	30.48%	11.22%	45.78%	17.38%
Dividend Yield	6.28%	8.15%	7.76%	7.87%	8.48%	9.42%
Payout Ratio	59.15%	8050.00%	30.91%	-	73.47%	-
Buyback Yield / Dilution	-0.43%	0.33%	-2.39%	4.40%	0.77%	-0.15%
Total Shareholder Return	5.85%	8.47%	5.36%	12.27%	9.24%	9.27%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.